The pathological roles of environmental and redox stresses in cardiovascular diseases

被引:29
作者
Ichihara, Sahoko [1 ]
机构
[1] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie 5148507, Japan
基金
日本学术振兴会;
关键词
Environmental cardiology; Oxidative stress; Redox-regulated transcription factors; Molecular mechanisms; Cardiovascular diseases; ACTIVATED RECEPTOR-ALPHA; NRF2 ENHANCES SUSCEPTIBILITY; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; PPAR-ALPHA; SUPEROXIDE-DISMUTASE; TRANSCRIPTION FACTOR; AH RECEPTOR; DNA-BINDING; CARDIAC DYSFUNCTION;
D O I
10.1007/s12199-012-0326-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Oxidative stress and inflammation are implicated in cardiovascular diseases such as atherosclerosis, reperfusion injury, hypertension, and heart failure. High levels of oxidative stress resulting from increased cardiac generation of reactive oxygen species (ROS) is thought to contribute to contractile and endothelial dysfunction, apoptosis and necrosis of myocytes, and extracellular matrix remodeling in the heart. ROS activate several transcription factors known as redox-regulated transcription factors, and these transcription factors play important roles in the pathophysiology of cardiovascular diseases. This review focuses on the pathological roles of environmental and redox stresses in cardiovascular diseases, especially severe cardiac dysfunction and the transition from compensated hypertrophy to heart failure. The aryl hydrocarbon receptor (AHR) and NF-E2 p45-related factor (Nrf2) are transcription factors involved in the regulation of drug-metabolizing enzymes. AHR has been studied as a receptor for environmental contaminants and as a mediator of chemical toxicity. However, other roles for AHR in cardiac and vascular development have recently been described. Moreover, Nrf2 protects against oxidative stress by increasing the transcription of genes, including those for several antioxidant enzymes. The roles of these transcription factors, AHR and Nrf2 in angiogenesis are also discussed in this review.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [1] The Impact of Exercise on Redox Equilibrium in Cardiovascular Diseases
    Sutkowy, Pawel
    Wroblewska, Joanna
    Wroblewski, Marcin
    Nuszkiewicz, Jaroslaw
    Modrzejewska, Martyna
    Wozniak, Alina
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [2] Pathological Roles of Iron in Cardiovascular Disease
    Kobayashi, Motoi
    Suhara, Tomohiro
    Baba, Yuichi
    Kawasaki, Nicholas K.
    Higa, Jason K.
    Matsui, Takashi
    CURRENT DRUG TARGETS, 2018, 19 (09) : 1068 - 1076
  • [3] Emerging roles of Sirtuin 2 in cardiovascular diseases
    Taneja, Arushi
    Ravi, Venkatraman
    Hong, Jun Young
    Lin, Hening
    Sundaresan, Nagalingam Ravi
    FASEB JOURNAL, 2021, 35 (10)
  • [4] Roles of Sirtuins in Cardiovascular Diseases: Mechanisms and Therapeutics
    Ding, Yang-Nan
    Wang, Hui-Yu
    Chen, Xiao-Feng
    Tang, Xiaoqiang
    Chen, Hou-Zao
    CIRCULATION RESEARCH, 2025, 136 (05) : 524 - 550
  • [5] Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases
    Deidda, Martino
    Noto, Antonio
    Bassareo, Pier P.
    Dessalvi, Christian Cadeddu
    Mercuro, Giuseppe
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [6] Unraveling the Intricate Roles of Exosomes in Cardiovascular Diseases: A Comprehensive Review of Physiological Significance and Pathological Implications
    Zhang, Shuai
    Yang, Yu
    Lv, Xinchen
    Liu, Wendong
    Zhu, Shaohua
    Wang, Ying
    Xu, Hongfei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
  • [7] Selenium as a Modulator of Redox Reactions in the Prevention and Treatment of Cardiovascular Diseases
    Leszto, Klaudia
    Biskup, Laura
    Korona, Klaudia
    Marcinkowska, Weronika
    Mozdzan, Maria
    Wegiel, Andrzej
    Mlynarska, Ewelina
    Rysz, Jacek
    Franczyk, Beata
    ANTIOXIDANTS, 2024, 13 (06)
  • [8] Emerging roles of ferroptosis in cardiovascular diseases
    Wang, Kai
    Chen, Xin-Zhe
    Wang, Yun-Hong
    Cheng, Xue-Li
    Zhao, Yan
    Zhou, Lu-Yu
    Wang, Kun
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [9] Roles of prostanoids in the pathogenesis of cardiovascular diseases
    Yuhki, K.
    Kashiwagi, H.
    Kojima, F.
    Kawabe, J.
    Ushikubi, F.
    INTERNATIONAL ANGIOLOGY, 2010, 29 (02) : 19 - 27
  • [10] The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases
    Park, S.
    Mathis, K. W.
    Lee, I. K.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2014, 15 (01) : 45 - 53